PLXNB2 and breast cancer: Gurrapu et al. showed that upon knockdown of PLXNB2 or its ligand semaphoemaphoringrin 4C in different BC cell lines, growth was dramatically inhibited along with impairment of G2/M phase transition, cytokinesis defects, and cell senescence [31].